Download Citation
Article Source:
Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
Tepper PG,
Mardekian J,
Masseria C,
Phatak H,
Kamble S,
et al.
(2018)
Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban.
PLOS ONE 13(11): e0205989.
https://doi.org/10.1371/journal.pone.0205989